German maker of personal-care products Beiersdorf Aktiengesellschaft said Jan. 8 that it has partnered with Insilico Medicine Inc. to work on discovering new and safe bioactive ingredients for a specific skin indication.
The company said it will use Insilico Medicine's next-generation artificial intelligence to generate and analyze new molecules for specific skin indications.
Beiersdorf, which makes Nivea brand products said the bioactive ingredients will serve as the basis for developing skin care products.
"We are delighted to now be working with Insilico Medicine as a veritable expert when it comes to artificial intelligence. We are able to evaluate new active ingredients significantly more quickly and more efficiently by simulating biological effects in silico. This enables us to cater even better to the consumers' as yet unmet skin care needs," May Shana'a, Beiersdorf's senior corporate vice president for research and development, said in a statement.